| Primary |
|
| Prothrombin Level Decreased |
66.7% |
| Diarrhoea |
33.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
22.8% |
| Product Used For Unknown Indication |
14.6% |
| Pain |
8.9% |
| Headache |
6.4% |
| Bronchitis |
4.3% |
| Hypertension |
4.3% |
| Myalgia |
4.3% |
| Tooth Disorder |
4.3% |
| Gastroenteritis |
3.9% |
| Breast Cancer |
3.6% |
| Back Pain |
2.8% |
| Rheumatoid Arthritis |
2.8% |
| Gastrointestinal Disorder |
2.5% |
| Nasopharyngitis |
2.5% |
| Pyrexia |
2.5% |
| Self Injurious Behaviour |
2.1% |
| Serum Ferritin Increased |
2.1% |
| Asthma |
1.8% |
| Sideroblastic Anaemia |
1.8% |
| Sleep Disorder |
1.8% |
|
| Vomiting |
16.4% |
| Stevens-johnson Syndrome |
9.6% |
| Neutropenia |
6.8% |
| Renal Failure Acute |
6.8% |
| Jaundice |
5.5% |
| Pancytopenia |
5.5% |
| Pyrexia |
5.5% |
| Thrombocytopenia |
5.5% |
| Cytolytic Hepatitis |
4.1% |
| Prothrombin Time Ratio Decreased |
4.1% |
| Prothrombin Time Shortened |
4.1% |
| Sinus Arrhythmia |
4.1% |
| Anaemia Haemolytic Autoimmune |
2.7% |
| Hypoglycaemia |
2.7% |
| Lung Neoplasm Malignant |
2.7% |
| Orthostatic Hypotension |
2.7% |
| Overdose |
2.7% |
| Pancreatitis Acute |
2.7% |
| Porphyrins Urine Increased |
2.7% |
| Skin Necrosis |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.7% |
| Product Used For Unknown Indication |
14.0% |
| Pain |
7.9% |
| Hypertension |
5.7% |
| Ill-defined Disorder |
5.2% |
| Pyrexia |
4.3% |
| Rheumatoid Arthritis |
3.9% |
| Prophylaxis |
3.8% |
| Atrial Fibrillation |
3.7% |
| Prostate Cancer |
3.6% |
| Constipation |
3.4% |
| Depression |
3.3% |
| Thrombosis Prophylaxis |
3.2% |
| Nausea |
2.9% |
| Breast Cancer |
2.6% |
| Anxiety |
2.2% |
| Hiv Infection |
1.9% |
| Insomnia |
1.6% |
| Non-small Cell Lung Cancer |
1.6% |
| Osteoporosis |
1.6% |
|
| Weight Decreased |
12.6% |
| Vomiting |
11.2% |
| Drug Toxicity |
6.3% |
| Thrombocytopenia |
6.3% |
| Renal Failure Acute |
5.6% |
| Toxic Skin Eruption |
5.6% |
| Vascular Purpura |
5.6% |
| Pyrexia |
4.9% |
| Tachycardia |
4.9% |
| Hyponatraemia |
4.2% |
| Pulmonary Embolism |
4.2% |
| Febrile Bone Marrow Aplasia |
3.5% |
| Hemiplegia |
3.5% |
| Malaise |
3.5% |
| Renal Failure |
3.5% |
| Subcutaneous Haematoma |
3.5% |
| General Physical Health Deterioration |
2.8% |
| Motor Dysfunction |
2.8% |
| Muscle Haemorrhage |
2.8% |
| Rectal Haemorrhage |
2.8% |
|
